DrPKay.com

Dawkins RL, Kay PH, Garlepp MJ, Christiansen FT.  Immunogenetics of spontaneous, drug-induced, and experimental myasthenia gravis. Ann NY Acad Sci 505:398-406 (1987).

Dawkins RL, Martin E, Kay PH, Garlepp MJ, Wilton AN, Stuckey MS.  Heterogeneity of steroid 21-hydroxylase genes in classical congenital adrenal hyperplasia. J. Immunogenet 14:89-98 (1987).

Kay PH, Dawkins RL, Bowling AT, Bernoco D.  Heterogeneity and linkage of equine C4 and steroid 21-hydroxylase genes.  J. Immunogenet 14:247-253 (1987).

Kay PH, Dawkins RL, Bowling AT, Bernoco D.  Polymorphism of the acetylcholine receptor in the horse.  Veterinary Record 120:363-365 (1987).

Kay PH, Grimsley G, Dawkins RL, Charoenwong P.  MHC supratypes as markers of null and defective C4 alleles in a Thai/Chinese population: relevance to disease susceptibility.  Disease Markers 5:43-47 (1987).

Kay PH, Dawkins RL, Bowling AT, Bernoco D.  Electrophoretic polymorphism and molecular structure of equine C3.  Animal Genetics 17:209-215 (1986).

Musk AW, Zilko PJ, Manners P, Kay PH, Kamboh MI.  Genetic studies in familial fibrosing alveolitis. Possible linkage with immunoglobulin allotypes (Gm).  Chest 89:206-210 (1986).

Warlow RS, Uko G, McCluskey J, Kay PH, Christiansen FT, Dawkins RL.  Extractable nuclear antigen (ENA) autoantibodies in SLE: an immunogenetic relationship with HLA, C4 and Bf alleles.  Clin Exp Immunol 63:419-427 (1986).

Day MJ, Kay PH, Clark WT, Shaw SE, Penhale WJ, Dawkins RL.  Complement C4 allotype association with and serum C4 concentration in an autoimmune disease in the dog. Clin Immunol Immunopathol 35:85-91 (1985).

Kay PH, Dawkins RL, Christiansen FT.  Sex influences transmission of the supratype, ssociated with the C2 deficiency allele: a possible mechanism for the maintenance of heterozygosity and disease susceptibility. Hum Immunol 12:185-189 (1985).

Kay PH, Dawkins RL, Penhale JW.  The molecular structure of different polymorphic forms of canine C3 and C4.  Immunogenetics 21:313-319 (1985).

Kay PH, Natsuume-Sakai S, Hayakawa J, Dawkins RL.  Different allotypes of C3, degrade at different rates.  Immunogenetics 22:563-569 (1985).

Kay PH, Wilton AN, Dawkins RL.  Preferential paternal transmission of the diabetogenic supratype marked by HLA B18 BfF1 DR3.  Journal of Immunogenetics 12:327-329 (1985).

Kelly H, McCann VJ, Kay PH, Dawkins RL, TI  Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles.  Immunogenetics 22:643-651 (1985).

Uko G, Dawkins RL, Kay PH, Christiansen FT, Hollingsworth PN,  CR1 deficiency in SLE: acquired or genetic?.  Clin Exp.Immunol 62:329-336 (1985).

Warlow RS, Garlepp M, Feeney D, Kay PH, Swanson N, Dawkins RL.  Antiacetylcholine receptor and antinuclear antibodies in myasthenia gravis.  Correlation with HLA, sex and Gm.  Exp Clin Immunogenet 2:158-163 (1985).

Warlow RS, Kay PH, McCluskey J, Uko G, Dawkins RL.  Secondary Sjogren’s syndrome and chromosome six markers.  Tissue Antigens 25:247-254 (1985).

Garlepp MJ, Kay PH, Farrow BR, Dawkins RL.  Autoimmunity in spontaneous myasthenia gravis in dogs.  Clin Immunol Immunopathol 31:301-306 (1984).

Kay PH, Dawkins RL.  Genetic polymorphism of complement C4 in the dog.  Tissue Antigens 23:151-155 (1984).

McCann VJ, McCluskey J, Kelly H, Kay PH, Zilko PJ, Christiansen FT, Dawkins RL.  Thyrogastric autoimmunity and MHC associated alleles at the C4 locus in patients with type 1 (insulin-dependent) diabetes.  Diabetologia 27:124-125 (1984).

Beilby JP, Dick M, Kay PH, Watson FE.  The microheterogeneities of thyroxine-binding globulin and alpha 1 protease inhibitor (alpha 1-antitrypsin) are interrelated.  Clinica Chimica Acta 133:51-63, (1983).

Christiansen FT, Dawkins RL, Uko G, McCluskey J, Kay PH, Zilko PJ.  Complement allotyping in SLE: association with C4A null.  Aust NZ J Med 13:483-488 (1983).

Dawkins RL, Christiansen FT, Kay PH, Garlepp M, McCluskey J, Hollingsworth PN, Zilko PJ.  Disease associations with complotypes, supratypes and haplotypes. Immunol Rev 70:1-22 (1983).

Dawkins RL, Kay PH, Christiansen FT.  Immunogenetics of rheumatoid arthritis. Ann Acad Med, Singapore 12:155-163 (1983).

Dawkins RL, Uko G, Christiansen FT, Kay PH.  Low C4 concentrations in insulin dependent diabetes mellitus. [letter].  Br Med J Clin Res 287:839 (1983).

Kay PH, McCluskey J, Christiansen FT, Feeney D, McCann VJ, Zilko PJ, Dawkins RL, O’Neill GJ.  Complement allotyping reveals new genetic markers in rheumatoid arthritis and diabetes mellitus.  Tissue Antigens 21:159-160 (1983).

McCann VJ, McCluskey J, Kay PH, Zilko PJ, Christiansen FT, Dawkins RL.  cHLA and complement genetic markers in diabetic retinopathy [letter].  Diabetologia 24:221 (1983).

McCluskey J, , McCann VJ, Kay PH, Zilko PJ, Christiansen FT, O’Neill GJ, Dawkins RL.  HLA and complement allotypes in Type 1 (insulin-dependent) diabetes.  Diabetologia 24:162-165 (1983).

McCluskey J, Kay PH, Stuckey M, Christiansen FT, Dawkins RL, Wilson G.  MHC “supratype” predicting heterozygous 21-hydroxylase deficiency [letter].  Lancet 1:764-765 (1983).

Uko G, Christiansen FT, Dawkins RL, Kay PH.  Low serum C4 concentrations in insulin dependent diabetes mellitus.  [letter].  Br Med J Clin Res 286:1748-1749, (1983).

Garlepp MJ, Kay PH, Dawkins RL.  The diagnostic significance of autoantibodies to the acetylcholine receptor.  J Neuroimmunol 3:337-350 (1982).

O’Neill GJ, Nerl CW, Kay PH, Christiansen FT, McCluskey J, Dawkins RL.  Complement C4 is a marker for adult rheumatoid arthritis [letter].  Lancet 2:214 (1982).

Garlepp MJ, Kay PH, Dawkins RL, Bucknall RC, Kemp A.  Cross-reactivity of anti-acetylcholine receptor autoantibodies.  Muscle & Nerve 4:282-288 (1981).